Edison, NJ, United States of America

Pak-Kan A Lo

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1978-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pak-Kan A Lo. Retrieved from https://idiyas.com/inventor/pak-kan-a-lo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1978-1983

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pak-Kan A Lo

Introduction

Pak-Kan A Lo is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the solubilization of drugs that are otherwise insoluble in water. With a total of 2 patents, his work has the potential to improve treatment options for various parasitic infections.

Latest Patents

One of his latest patents focuses on the solubilization of ivermectin, an antiparasitic agent that is typically insoluble and unstable in water. This innovation involves the formation of colloidal particles, known as micelles, using surface-active agents as solubilizers. The resulting liquid formulations are suitable for both parenteral and oral administration, providing effective treatment for parasitic infections.

Another significant patent by Pak-Kan A Lo is the solubilization of Rafoxanide. This patent describes the formation of a soluble complex of the insoluble drug Rafoxanide with polyvinylpyrrolidone and water. The complex is created by combining the drug with polyvinylpyrrolidone in a suitable water-miscible organic solvent, such as acetone or glycerol formal, and water. This innovative approach allows the complex to remain in aqueous solution, making it suitable for injection to treat fasciola or liver fluke infections.

Career Highlights

Pak-Kan A Lo is currently employed at Merck & Co., Inc., where he continues to advance his research in drug solubilization. His work has garnered attention for its practical applications in improving drug delivery systems.

Collaborations

One of his notable coworkers is James B Williams, with whom he has collaborated on various projects within the pharmaceutical field.

Conclusion

Pak-Kan A Lo's innovative contributions to drug solubilization demonstrate his commitment to enhancing treatment options for parasitic infections. His patents reflect a significant advancement in pharmaceutical formulations, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…